Overview
- Legal name
- BNB PLUS CORP.
- Registered location
- STONY BROOK, NY, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- May 20, 2026
Read company summary
BNB PLUS CORP. is associated with UEI UUVEKDFQHTD7 and CAGE 5XPT1 in public federal records. AcornBids currently links 7 prime awards totaling $165.7K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Biological Product (except Diagnostic) Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists STONY BROOK, NY, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 17, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- BNB PLUS CORP.
- UEI
- UUVEKDFQHTD7
- CAGE
- 5XPT1
- Registered address
- 25 HEALTH SCIENCES DR STE 228, STONY BROOK, NY, 11790, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Apr 29, 2026
- Initial registration
- Mar 18, 2010
- Entity start
- Mar 18, 2010
- SAM updated
- Apr 29, 2026
- Registration expires
- Apr 28, 2027
- Fiscal year end
- Sep 30
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 7 awards and $165,680 in reported obligations to this legal entity. Source
- Recorded awards include Biological Product (except Diagnostic) Manufacturing (NAICS 325414); this classification is not proof of every company capability. Source
- An example award describes: 8512093939!MISCELLANEOUS Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Histories follow awards currently assigned to this recipient and may include transactions under an earlier recipient. Coverage: 7 of 7 selected awards. Select a period to explore its awards.
Funding change
Dated, valued transaction obligations in equal-length adjacent periods; missing records are unknown. Default: last completed federal fiscal year. Percentage is unavailable when the prior period has no positive reported obligations.
| Measure | Reported value |
|---|---|
| Current period | Oct 1, 2025 – Sep 30, 2026 |
| Current obligations | $20.5K |
| Prior period | Oct 1, 2024 – Sep 30, 2025 |
| Prior obligations | $145.1K |
| Change | $-124.6K |
| Growth | -85.8% |
Where the work is performed
State tile map; darker tiles have larger absolute net obligations. Outlined tiles indicate net deobligations. Unshaded tiles have no reported transactions in this selection. Other locations appear in the table.
Agencies
| Category | Period obligations | Awards |
|---|---|---|
| Department of Defense | $165.7K | 7 |
Offices
| Category | Period obligations | Awards |
|---|---|---|
| DLA LAND AND MARITIME | $129.4K | 6 |
| DLA LAND AND MARITIME | $36.3K | 1 |
Naics
| Category | Period obligations | Awards |
|---|---|---|
| 325414 — Biological Product (except Diagnostic) Manufacturing | $165.7K | 7 |
Psc
| Category | Period obligations | Awards |
|---|---|---|
| 6505 — Drugs and Biologicals | $165.7K | 7 |
Vehicles
| Category | Period obligations | Awards |
|---|---|---|
| SPE7MX21D5033 | $165.7K | 7 |
States
| Category | Period obligations | Awards |
|---|---|---|
| NY | $165.7K | 7 |
Set Asides
| Category | Period obligations | Awards |
|---|---|---|
| Unclassified | $165.7K | 7 |
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| SPE7M126F32208512093939!MISCELLANEOUS | Department of Defense | $20.5K | May 6, 2026 | May 29, 2026 |
| SPE7M126F11558511815261!MISCELLANEOUS | Department of Defense | $1 | Dec 15, 2025 | Mar 25, 2026 |
| SPE7MX25F251K8511644365!MISCELLANEOUS | Department of Defense | $36.3K | Sep 16, 2025 | Dec 26, 2025 |
| SPE7M125F23168511450976!MISCELLANEOUS | Department of Defense | $36.3K | Jun 17, 2025 | Sep 25, 2025 |
| SPE7M125F13998511273757!MISCELLANEOUS | Department of Defense | $36.3K | Mar 25, 2025 | Jul 3, 2025 |
| SPE7M125F06878511082660!MISCELLANEOUS | Department of Defense | $36.3K | Dec 17, 2024 | Mar 27, 2025 |
| SPE7M124F41758510924438!MISCELLANEOUS | Department of Defense | $0 | Sep 27, 2024 | Jan 5, 2025 |
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Apr 29, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Mar 18, 2010 |
| Entity start | Mar 18, 2010 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 325414 — Biological Product (except Diagnostic) Manufacturing | Not reported |
| 541713 — Research and Development in Nanotechnology | Not reported |
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| BETH JANTZEN | Government business | Contact method not published | SAM registration | Not available |
| KATIE PALAMAR | Alternate government business | Contact method not published | SAM registration | Not available |
| BETH JANTZEN | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 325414 — Biological Product (except Diagnostic) Manufacturing
- 541713 — Research and Development in Nanotechnology
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit